Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

 

Current Issue

January-February 2026 (Vol. 40 Issue 1) Table of Contents
In Vivo: 40 (1)

Issue highlights

  • Prognosis and Risk Factors in Patients With Non-radical Circumferential Resection Margin After Rectal Cancer Surgery
  • Splenectomy in Ovarian Cancer Cytoreductive Surgery: Pre-operative Prediction of Disease, Peri-operative Outcomes and Post-operative Adherence to Antimicrobial Prophylaxis and Immunisation
  • Low-temperature Versus High-temperature Sintering: Regenerative and Osteoimmunological Insights from Bio-Oss®, Ti-Oss® in Sinus Lift Surgery
  • Serum Zinc Levels and Skin-related Adverse Events During Systemic Therapy for Renal Cell Carcinoma
  • Modulating ACVRL1 Expression in HMEC1 Cells as a Simplified In Vitro Model for Hereditary Hemorrhagic Telangiectasia (HHT) Type 2 Studies

 


 

⚠️ Important Notice: Fraudulent Emails

We have been informed of fraudulent emails impersonating IIAR editors and requesting financial assistance or bank transfers. These messages do NOT come from us.

Please note that the ONLY official IIAR email domains are:

  • @iiar-anticancer.org
  • @iiar-submissions.com

If you receive any suspicious message from another address—especially requests involving money—do not respond. Report the message as spam/phishing and contact us directly through our official email addresses.

Thank you for your vigilance.


Two Special Issues in 2025:

  1. "Diabetes: New Antidiabetic Agents; Stem Cell Therapy; Pancreas Transplantation  – 2025" is now published and you may find it here.
  2. "In Vivo, In Vitro and In Silico Characterization of Permanent and Biodegradable Implants" is now published and you may find it here.

Featured Articles

  • Coronavirus Disease (COVID-19): A Machine Learning Bibliometric Analysis
    June 05, 2020
  • Curcumin Suppression of Cytokine Release and Cytokine Storm. A Potential Therapy for Patients with...
    January 19, 2015
  • Anti-inflammatory Activity of β-Carotene, Lycopene and Tri-n-butylborane, a Scavenger of...
    February 23, 2018
  • Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving...
    April 25, 2018
  • Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process
    June 05, 2020

Latest Articles

  • Open Access
    Low-temperature Versus High-temperature Sintering: Regenerative and Osteoimmunological Insights from Bio-Oss®, Ti-Oss® in Sinus Lift Surgery
    TADAS KORZINSKAS, REINER SCHNETTLER, DENIS RIMASHEVSKIY, BIRZHAN MALIK, BAURZHAN DAKENOV, DIANA BAGDONIENE, OLE JUNG and MIKE BARBECK
    In Vivo January 2026, 40 (1) 322-332; DOI: https://doi.org/10.21873/invivo.14195
  • Open Access
    Cannabidiol Enhances SIRT1 and Autophagy for the Maintenance of Human Mesenchymal Stem Cells
    PHONGSAKORN CHUEAPHROMSRI, PHONGSAKORN KUNHORM, AREECHUN SOTTHIBUNDHU, NIPHA CHAICHAROENAUDOMRUNG and PARINYA NOISA
    In Vivo January 2026, 40 (1) 222-234; DOI: https://doi.org/10.21873/invivo.14186
  • Open Access
    Clinical Features, Prognosis, and Prognostic Factors of Remnant Gastric Cancer Patients Who Received Potentially Curative Gastrectomy
    TORU AOYAMA, HARUHIKO CHO, HIDEAKI SUEMATSU and KENTARO HARA
    In Vivo January 2026, 40 (1) 422-429; DOI: https://doi.org/10.21873/invivo.14206
  • Open Access
    Nutritional Assessment of Pesticide-associated Metabolic Stress in Plant-based Diets
    RAMONA ALINA TOMUȚA, MARIA FLAVIA GÎTEA, MARC CRISTIAN GHITEA, EVELIN CLAUDIA GHITEA, TIMEA CLAUDIA GHITEA and FLORIN BANICA
    In Vivo January 2026, 40 (1) 136-150; DOI: https://doi.org/10.21873/invivo.14179
  • Open Access
    Serum Zinc Levels and Skin-related Adverse Events During Systemic Therapy for Renal Cell Carcinoma
    SHINPEI SAITO, TOMOKAZU SAZUKA, HIROAKI SATO, YURI WATANABE, FUMIYA YOKOCHI, KOHEI TOMA, YUSUKE ONODA, KOTARO NAGAOKA, SANGJON PAE, KODAI SATO, KEISUKE ANDO, YASUTAKA YAMADA, YUSUKE IMAMURA and SHINICHI SAKAMOTO
    In Vivo January 2026, 40 (1) 333-340; DOI: https://doi.org/10.21873/invivo.14196
  • Open Access
    Pterostilbene Attenuates High Fat Diet-induced Obesity and Hepatic Dysfunction in Rats: A Functional Evaluation Based on Taiwan’s Health Food Assessment Criteria
    CHIEN-JUNG HUANG, SHIH-CHANG TSAI, JAI-SING YANG, PO-CHUEN SHIEH, YU-JEN CHIU, DA-TIAN BAU and CHIH-HSIN HUNG
    In Vivo January 2026, 40 (1) 628-639; DOI: https://doi.org/10.21873/invivo.14225
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks
The Antitumor Activities of Flavonoids
Melanoma: Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification
Muscle Regeneration: Cellular and Molecular Events
Radioprotection
Intraarterial Hepatic Chemoembolization of Liver Metastases from Colorectal Cancer Adopting Irinotecan-eluting Beads: Results of a Phase II Clinical Study
Visit the official website of In Vivo.
 
Back to top
In Vivo

© 2026 In Vivo

Powered by HighWire